from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3156/nuoL

LFCtreatmentdescriptionclass of inhibitor

-0.242

Amikacinug/mL Amikacintranslation

-1.213

Cap5-10ug/mL Capreomycintranslation

-1.571

Rox10-50 ug/mL Roxithromycintranslation

0.318

SM2-5 ug/mL Streptomycintranslation

-0.112

Tet5-10 ug/mL Tetracyclinetranslation

0.110

Rif0.2-5ug/mL Rifampicintranscription

-0.982

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.281

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.636

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.358

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.601

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.070

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.720

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.005

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.022

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.946

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.850

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.616

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.483

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.418

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.028

KCN5-20 ug/mL Potassium cyaniderespiration

-0.132

NaN30.2-2 mM Sodium aziderespiration

-1.107

Nigericin50 uM Nigericinrespiration

-0.156

TRC10-150 ug/mL Triclosanrespiration

-0.202

TRZ10-25 ug/mL Thioridazinerespiration

-1.212

Valinomycin0.5-10 uM Valinomycinrespiration

-1.042

ZnSO42 mM ZnSO4respiration

0.144

menadione6-10 ug/mL Menadionerespiration

-0.668

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.123

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.483

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.675

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.509

NRP_1Non-replicating persistence stage 1dosRassociated

0.585

Amp0.2mg/mL AmpicillincellWall

0.181

Cephalexin20-100 ug/mL CephalexincellWall

-0.565

Cerulenin0.32-5 ug/mL CerulenincellWall

1.339

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.481

EMB10-20 ug/mL EthambutolcellWall

-0.230

Eta12-40 ug/mL EthionamidecellWall

-0.057

INH0.2-0.4 ug/mL IsoniazidcellWall

0.243

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.543

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.590

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.738

BZA0.12 mg/mL BenzamidearomaticAmides

1.308

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.904

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.790

H2O24 mM hydrogen peroxideDNAdamaging

-0.574

Levo10 ug/mL LevofloxacinDNAdamaging

0.974

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.343

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.056

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.215

UVUV-irradiationDNAdamaging

-0.934

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.290

Antimycin12.5-50 ug/mL Antimycin A?

-0.589

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.267

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.319

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.892

PA8240.2-2 ug/mL PA-824?

-0.492

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.421

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.983

Verapamil50 uM Verapamil?

-0.514

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.712

methoxatin10-20 ug/mL Methoxatin?